Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
769.50    4.50 (0.59%)
Bid:
770.00
Ask:
772.50
Spread: 2.50 (0.325%)
Market Cap: £886.26m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Kainos Director/PDMR Shareholding

4 Jul 2018 16:51

RNS Number : 6382T
Kainos Group plc
04 July 2018
Β 

4 July 2018

Β 

Kainos Group plc

Β 

("Kainos" or the "Company)

Director / PDMR shareholdings

The Company announces that on 4 July 2018, share awards (the "Awards") approved by the Board of Directors of the Company under:

(i) the Kainos Group Performance Share Plan (the "PSP Awards"), in the form of nominal value options over Ordinary Shares were awarded to executive directors and executive managers of the Company. The PSP Awards vest, other than in exceptional circumstances, over a three year period from 4 July 2018. The performance conditions associated with the PSP Awards are as follows:

Β 

(a) 50% of each PSP Award is subject to a performance condition based on the Company's Earnings Per Share ("EPS") Growth measured over the three financial years commencing 1 April 2018. This portion of the PSP Award will:

Β· not vest at all if EPS Growth over the measurement period is less than 9%;

Β· vest in respect of 30% if EPS Growth over the measurement period is 9%;

Β· vest in full if EPS Growth over the measurement period is 16% or higher;

Β· vest proportionately, calculated on a straight line basis if EPS Growth over the measurement period is higher than 9% but less than 16%.

Β 

(b) 50% of each PSP Award is subject to a performance condition based on the Company's Total Shareholder Return ("TSR") Growth per ordinary share measured over the period of three years commencing 4 July 2018. This portion of the PSP Award will:

Β· not vest at all if TSR Growth over the measurement period is less than 9%;

Β· vest in respect of 30% if TSR Growth over the measurement period is 9%;

Β· vest in full if TSR Growth over the measurement period is 16% or higher;

Β· vest proportionately, calculated on a straight line basis if TSR Growth over the measurement period is higher than 9% but less than 16%.

Β 

Β 

(ii) Kainos Group plc SAYE Plan (the "SAYE Awards"), in the form of options at 20% discount to market value were awarded to all staff including executive directors and executive managers of the Company.

Β 

Β 

Β 

Β 

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them.

Β (A19 Market Abuse Regulation)

Β 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Brendan Mooney

2.

Reason for the notification

a.

Position/status

CEO

b.

Initial notification

/Amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Kainos Group plc

b.

LEI

213800H2PQMIF3OVZY47

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument/

type of instrument

Identification code

Options over Ordinary Shares of Β£0.005 each

Β 

KNOS

b.

Nature of the transaction

PSP Share Awards 2018

c.

Price(s) and volume(s)

Β 

PSP Award

Exercise Price(s)

Volume(s)

Β£0.005

17,621

Β 

Β 

d.

Aggregated information

Β· Aggregated volume

Β· Price

Β 

N/A

e.

Date of the transaction

2018-07-04

f.

Place of the transaction

Outside a trading venue

Β 

Β 

Β 

Β 

Β 

Β 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Richard McCann

2.

Reason for the notification

a.

Position/status

CFO/COO

b.

Initial notification

/Amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Kainos Group plc

b.

LEI

213800H2PQMIF3OVZY47

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument/

type of instrument

Identification code

Options over Ordinary Shares of Β£0.005 each

Β 

KNOS

b.

Nature of the transaction

PSP and SAYE Share Awards 2018

c.

Price(s) and volume(s)

SAYE Award1

Exercise Price(s)

Volume(s)

Β£3.3627

1,070

Β 

PSP Award2

Exercise Price(s)

Volume(s)

Β£0.005

19,552

Β 

1. Subject to a 3 year vesting period other than in exceptional circumstances.

2. Subject to the PSP Awards vesting criteria.

Β 

d.

Aggregated information

Β· Aggregated volume

Β· Price

Β 

N/A

e.

Date of the transaction

2018-07-04

f.

Place of the transaction

Outside a trading venue

Β 

Β 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Paul Gannon

2.

Reason for the notification

a.

Position/status

Sales Director

b.

Initial notification

/Amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Kainos Group plc

b.

LEI

213800H2PQMIF3OVZY47

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument/

type of instrument

Identification code

Options over Ordinary Shares of Β£0.005 each

Β 

KNOS

b.

Nature of the transaction

PSP and SAYE Share Awards 2018

c.

Price(s) and volume(s)

Options Award (equivalent to UK SAYE)1, 2

Exercise Price(s)

Volume(s)

Β£3.3627

1,070

Β 

PSP Award3

Exercise Price(s)

Volume(s)

Β£0.005

15,690

Β 

1. Subject to 3 year vesting period other than in exceptional circumstances.

2. Mr Gannon's option awards are under an unapproved option scheme in Republic of Ireland to replicate SAYE awards to U.K. staff.

3. Subject to the PSP Awards vesting criteria.

d.

Aggregated information

Β· Aggregated volume

Β· Price

Β 

N/A

e.

Date of the transaction

2018-07-04

f.

Place of the transaction

Outside a Trading Venue

Β 

Ends

Β 

For further information, please contact:

Β 

Kainos via FTI Consulting LLP

Β 

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

Β 

Investec Bank plc +44Β 20 7597 5970

Β 

Patrick Robb / Sebastian Lawrence

Β 

Canaccord Genuity +44 20 7523 4606

Β 

Simon Bridges / Emma Gabriel

Β 

FTI Consulting LLP +44 20 3727 1000

Β 

Matt Dixon / Jamie Ricketts

Β 

Β 

About Kainos

Kainos Group plc is a UK-based provider of Digital Services and Digital Platforms.

The Group's Digital Services include full lifecycle development and support of customised Digital Services for government and commercial customers. Kainos is also the leading European partner for Workday Inc. ('Workday') responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise and, now, government customers.

The Group's Digital Platforms comprise specialised digital products in the mobile healthcare and automated testing arenas. Smart is an automated testing platform for Workday customers; Evolve Electronic Medical Records ('EMR') is the market leading product for the digitisation of patient notes in the Acute sector of the NHS; and Evolve Integrated Care ('IC') is a SaaS-based integrated care platform for the NHS and international healthcare providers; and Smart is an automated testing platform for Workday customers.

Kainos has over 1,150 people across eleven offices in Europe and the USA, working interchangeably across its Services and Platforms divisions.

Kainos is listed on the London Stock Exchange (LSE: KNOS). For further information, please visitΒ www.kainos.com

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
DSHEASXLELNPEFF
Date   Source Headline
3rd Sep 20207:00 amRNSKainos Trading Update
1st Sep 20207:00 amRNSTotal Voting Rights
27th Aug 20204:27 pmRNSBoard Committee Membership
25th Aug 20204:46 pmRNSHolding(s) in Company
19th Aug 202010:10 amRNSNotice of AGM
5th Aug 20201:13 pmRNSDirector/PDMR Shareholding
31st Jul 202011:29 amRNSTotal Voting Rights
31st Jul 20208:39 amRNSAnnual Report 2020
27th Jul 20207:00 amRNSTrading Update and Special Dividend
3rd Jul 20201:56 pmRNSDirector/PDMR Shareholding
1st Jul 202012:20 pmRNSTotal Voting Rights
30th Jun 20205:10 pmRNSCorrection: Director/PDMR Shareholding
30th Jun 20201:59 pmRNSDirector/PDMR Shareholding
9th Jun 202011:39 amRNSDirector Declaration
9th Jun 20208:59 amRNSDirector/PDMR Shareholding
1st Jun 202011:51 amRNSTotal Voting Rights
28th May 20205:00 pmRNSHolding(s) in Company
26th May 20207:00 amRNSPreliminary results for year ended 31 March 2020
1st May 20209:19 amRNSTotal Voting Rights
23rd Apr 202012:07 pmRNSSecond Price Monitoring Extn
23rd Apr 202012:02 pmRNSPrice Monitoring Extension
16th Apr 20207:00 amRNSTrading Update
14th Apr 20204:37 pmRNSPrice Monitoring Extension
1st Apr 20201:09 pmRNSTotal Voting Rights
2nd Mar 20207:00 amRNSKainos acquires IntuitiveTEK LLC
31st Jan 202011:28 amRNSTotal Voting Rights
6th Jan 20209:41 amRNSTotal Voting Rights
19th Dec 20195:46 pmRNSHolding(s) in Company
9th Dec 20192:37 pmRNSCORRECTION: Director/PDMR Shareholding
6th Dec 20193:29 pmRNSHolding(s) in Company
6th Dec 20193:29 pmRNSDirector/PDMR Shareholding
5th Dec 201912:02 pmRNSPrice Monitoring Extension
3rd Dec 20193:42 pmRNSDirector/PDMR Shareholding
29th Nov 20194:00 pmRNSHolding(s) in Company
29th Nov 20193:54 pmRNSDirector/PDMR Shareholding
29th Nov 201911:00 amRNSTotal Voting Rights
28th Nov 201910:42 amRNSAppointment of Non-Executive Director
20th Nov 201912:07 pmRNSSecond Price Monitoring Extn
20th Nov 201912:02 pmRNSPrice Monitoring Extension
11th Nov 20197:01 amRNSKainos Acquires Formulate and Implexa
11th Nov 20197:00 amRNSInterim Results
1st Nov 201911:15 amRNSTotal Voting Rights
30th Sep 20193:14 pmRNSTotal Voting Rights
26th Sep 20191:15 pmRNSChairman Appointment & Committee Membership Change
26th Sep 201912:00 pmRNSResults of Annual General Meeting
5th Sep 20195:31 pmRNSHolding(s) in Company
4th Sep 20197:00 amRNSTrading Update
3rd Sep 20193:44 pmRNSHolding(s) in Company
2nd Sep 201910:50 amRNSTotal Voting Rights
21st Aug 20191:40 pmRNSNotice of Annual General Meeting 2019

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.